{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T14:44:50Z","timestamp":1698590690826},"reference-count":29,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T00:00:00Z","timestamp":1240531200000},"content-version":"vor","delay-in-days":4649,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[1996,8]]},"abstract":"<jats:p><jats:bold>Abstract:\u2002<\/jats:bold> Twenty\u2010one HIV negative Japanese patients with chronic hepatitis C who had congenital bleeding disorders, 15 hemophilia A, 3 hemophilia B, 1 von Willebrand's disease, 1 afibrinogenemia and 1 thrombasthenia, were treated with 9 million units 3 times a week of natural interferon (IFN)\u2010\u03b1 for 6 months. They were followed, biochemically and virologically, for at least 18 months after therapy discontinuation to evaluate the long\u2010term results. Liver biopsy, hepatitis C virus (HCV) genotyping and quantification of viral load by polymerase chain reaction (PCR) were performed to identify the predictors of a favorable response to IFN treatment. One male patient with hemophilia A dropped out because of general fatigue and was excluded from evaluation. Ten (50.0%) patients continued to be HCV RNA negative in serum together with normal ALT levels throughout the study. Subtype 1b and a high level of viremia significantly associated with an unfavorable outcome on the response to IFN although liver histology was not definitive for predicting the response. We concluded that a 6\u2010month treatment with high doses of natural IFN\u2010\u03b1 was effective in inducing a long\u2010term response without relapse of viremia in 50% of chronic hepatitis C patients with congenital bleeding disorders and that HCV subtype and pretreatment level of viremia were useful predictors of the response to IFN in treating such patients.<\/jats:p>","DOI":"10.1111\/j.1600-0609.1996.tb01355.x","type":"journal-article","created":{"date-parts":[[2010,7,18]],"date-time":"2010-07-18T13:47:32Z","timestamp":1279460852000},"page":"165-170","source":"Crossref","is-referenced-by-count":6,"title":["A long\u2010term follow\u2010up study of interferon treatment for chronic hepatitis C in Japanese patients with congenital bleeding disorders"],"prefix":"10.1111","volume":"57","author":[{"given":"M.","family":"Yamada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Urano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Isobe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Takamatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Imoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Hayakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.287.6407.1754"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1985.tb07444.x"},{"key":"e_1_2_1_4_2","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1182\/blood.V60.3.655.655","article-title":"Nonprogressive course of non\u2010A, non\u2010B hepatitis in multitransfused hemophiliacs","volume":"60","author":"Mannucci PM","year":"1982","journal-title":"Blood"},{"key":"e_1_2_1_5_2","first-page":"1259","article-title":"Chronic hepatitis in patients with hemophilia A: histologic studies in patients with intermittently abnormal liver function tests","volume":"60","author":"White GC","year":"1982","journal-title":"Blood"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)92264-0"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0676.1995.tb00659.x"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)91124-S"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115482"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840120409"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198911303212203"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198911303212204"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-115-9-700"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840210405"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(95)80109-X"},{"key":"e_1_2_1_16_2","first-page":"2151","article-title":"A statistical analysis of predictive factors of response to human lymphoblastoid interferon in patients with chronic hepatitis C","volume":"89","author":"Hayashi J","year":"1994","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840190505"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1989.tb07688.x"},{"key":"e_1_2_1_19_2","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1182\/blood.V78.7.1672.1672","article-title":"A randomized controlled trial of recombinant interferon\u2010\u03b1 in chronic hepatitis C in hemophiliacs","volume":"78","author":"Makris M","year":"1991","journal-title":"Blood"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.34.2_Suppl.S124"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02347513"},{"key":"e_1_2_1_22_2","first-page":"215","article-title":"Detection of hepatitis C virus RNA by a two\u2010stage polymerase chain reaction with two pairs of primers deduced from the 5\u2032\u2010noncoding region","volume":"60","author":"Okamoto H","year":"1990","journal-title":"Jpn J Exp Med"},{"key":"e_1_2_1_23_2","first-page":"16","article-title":"Quantification of hepatitis C virus by competitive reverse transcription\u2013polymerase chain reaction: increase of the virus in advanced liver disease","volume":"18","author":"Kato N","year":"1993","journal-title":"Hepatology"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-73-3-673"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840190538"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(68)90710-1"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840010511"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)92234-7"},{"key":"e_1_2_1_29_2","first-page":"1246","article-title":"A controlled study to determine the optimal dose regimen of interferon\u2010\u03b1 2b in chronic hepatitis C","volume":"90","author":"Hakozaki Y","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01316789"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.1996.tb01355.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.1996.tb01355.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T04:08:40Z","timestamp":1698379720000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.1996.tb01355.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,8]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1996,8]]}},"alternative-id":["10.1111\/j.1600-0609.1996.tb01355.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.1996.tb01355.x","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,8]]}}}